HOLX Quote, Financials, Valuation and Earnings

Becton, Dickinson & Co. has a net margin of 17.85% compared to Hologic, Inc.'s net margin of 8.37%. Hologic, Inc.'s return on equity of 11.59% beat Becton, Dickinson & Co.'s return on equity of 6.6%.

Hologic, Inc. has a consensus price target of $76.42, signalling upside risk potential of 1.94%. On the other hand Becton, Dickinson & Co. has an analysts' consensus of $204.83 which suggests that it could grow by 1.05%. Given that Hologic, Inc. has higher upside potential than Becton, Dickinson & Co., analysts believe Hologic, Inc. is more attractive than Becton, Dickinson & Co..

Hologic, Inc. has a beta of 0.695, which suggesting that the stock is 30.493% less volatile than S&P 500. In comparison Becton, Dickinson & Co. has a beta of 0.236, suggesting its less volatile than the S&P 500 by 76.383%.

Hologic, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Becton, Dickinson & Co. offers a yield of 2.06% to investors and pays a quarterly dividend of $1.05 per share. Hologic, Inc. pays -- of its earnings as a dividend. Becton, Dickinson & Co. pays out 71.53% of its earnings as a dividend. Becton, Dickinson & Co.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Hologic, Inc. quarterly revenues are $1B, which are smaller than Becton, Dickinson & Co. quarterly revenues of $5.9B. Hologic, Inc.'s net income of $187.3M is lower than Becton, Dickinson & Co.'s net income of $493M. Notably, Hologic, Inc.'s price-to-earnings ratio is 30.19x while Becton, Dickinson & Co.'s PE ratio is 34.77x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Hologic, Inc. is 4.15x versus 2.67x for Becton, Dickinson & Co.. Usually stocks with elevated PS ratios are considered overvalued.

Nuwellis, Inc. has a net margin of 17.85% compared to Hologic, Inc.'s net margin of 21.11%. Hologic, Inc.'s return on equity of 11.59% beat Nuwellis, Inc.'s return on equity of -1004.06%.

Hologic, Inc. has a consensus price target of $76.42, signalling upside risk potential of 1.94%. On the other hand Nuwellis, Inc. has an analysts' consensus of $13.00 which suggests that it could grow by 22885.1%. Given that Nuwellis, Inc. has higher upside potential than Hologic, Inc., analysts believe Nuwellis, Inc. is more attractive than Hologic, Inc..

Hologic, Inc. has a beta of 0.695, which suggesting that the stock is 30.493% less volatile than S&P 500. In comparison Nuwellis, Inc. has a beta of -0.186, suggesting its less volatile than the S&P 500 by 118.573%.

Hologic, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nuwellis, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Hologic, Inc. pays -- of its earnings as a dividend. Nuwellis, Inc. pays out -- of its earnings as a dividend.

Hologic, Inc. quarterly revenues are $1B, which are larger than Nuwellis, Inc. quarterly revenues of $2.2M. Hologic, Inc.'s net income of $187.3M is higher than Nuwellis, Inc.'s net income of $468K. Notably, Hologic, Inc.'s price-to-earnings ratio is 30.19x while Nuwellis, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Hologic, Inc. is 4.15x versus 0.54x for Nuwellis, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Quanterix Corp. has a net margin of 17.85% compared to Hologic, Inc.'s net margin of -83.31%. Hologic, Inc.'s return on equity of 11.59% beat Quanterix Corp.'s return on equity of -30.04%.

Hologic, Inc. has a consensus price target of $76.42, signalling upside risk potential of 1.94%. On the other hand Quanterix Corp. has an analysts' consensus of $7.00 which suggests that it could grow by 5.58%. Given that Quanterix Corp. has higher upside potential than Hologic, Inc., analysts believe Quanterix Corp. is more attractive than Hologic, Inc..

Hologic, Inc. has a beta of 0.695, which suggesting that the stock is 30.493% less volatile than S&P 500. In comparison Quanterix Corp. has a beta of 1.006, suggesting its more volatile than the S&P 500 by 0.60500000000001%.

Hologic, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quanterix Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Hologic, Inc. pays -- of its earnings as a dividend. Quanterix Corp. pays out -- of its earnings as a dividend.

Hologic, Inc. quarterly revenues are $1B, which are larger than Quanterix Corp. quarterly revenues of $40.2M. Hologic, Inc.'s net income of $187.3M is higher than Quanterix Corp.'s net income of -$33.5M. Notably, Hologic, Inc.'s price-to-earnings ratio is 30.19x while Quanterix Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Hologic, Inc. is 4.15x versus 2.07x for Quanterix Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Varex Imaging Corp. has a net margin of 17.85% compared to Hologic, Inc.'s net margin of 5.33%. Hologic, Inc.'s return on equity of 11.59% beat Varex Imaging Corp.'s return on equity of -13.35%.

Hologic, Inc. has a consensus price target of $76.42, signalling upside risk potential of 1.94%. On the other hand Varex Imaging Corp. has an analysts' consensus of $17.20 which suggests that it could grow by 36.51%. Given that Varex Imaging Corp. has higher upside potential than Hologic, Inc., analysts believe Varex Imaging Corp. is more attractive than Hologic, Inc..

Hologic, Inc. has a beta of 0.695, which suggesting that the stock is 30.493% less volatile than S&P 500. In comparison Varex Imaging Corp. has a beta of 0.861, suggesting its less volatile than the S&P 500 by 13.881%.

Hologic, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Varex Imaging Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Hologic, Inc. pays -- of its earnings as a dividend. Varex Imaging Corp. pays out -- of its earnings as a dividend.

Hologic, Inc. quarterly revenues are $1B, which are larger than Varex Imaging Corp. quarterly revenues of $228.9M. Hologic, Inc.'s net income of $187.3M is higher than Varex Imaging Corp.'s net income of $12.2M. Notably, Hologic, Inc.'s price-to-earnings ratio is 30.19x while Varex Imaging Corp.'s PE ratio is 17.58x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Hologic, Inc. is 4.15x versus 0.65x for Varex Imaging Corp.. Usually stocks with elevated PS ratios are considered overvalued.